PT-141 (5mg)

This research vial contains PT-141 (Bremelanotide), a synthetic peptide analog studied for its role in melanocortin receptor activation and neuroendocrine signaling. Researchers have examined PT-141 in preclinical studies for its influence on sexual behavior, vascular flow, and neurological activity.

Blend Composition (Per Vial):
PT-141 – 5mg

Key Characteristics:

• PT-141 (Bremelanotide): Peptide analog studied for melanocortin receptor activation

• Investigated for roles in neurovascular and behavioral response mechanisms

• Studied for peptide-driven modulation of CNS activity in preclinical research

• Sterile vial formulation designed for peptide stability and reproducibility

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.